BSX
Boston Scientific CorpCompany with tickers: BSX
CIK
885725
CUSIP
101137107
Shares Outstanding
1,486,355,179
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $4,663,000,000 | USD | 2025-03-31 | 10-Q | 2026-05-01 |
| Cost of Revenue | — | ||||
| Gross Profit | $3,210,000,000 | USD | 2025-03-31 | 10-Q | 2026-05-01 |
| Operating Expenses | $2,288,000,000 | USD | 2025-03-31 | 10-Q | 2026-05-01 |
| Research & Development | — | ||||
| Operating Income | $921,000,000 | USD | 2025-03-31 | 10-Q | 2026-05-01 |
| Net Income | — | ||||
| EPS (Basic) | $0.46 | USD/shares | 2025-03-31 | 10-Q | 2026-05-01 |
| EPS (Diluted) | $0.45 | USD/shares | 2025-03-31 | 10-Q | 2026-05-01 |